Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model

Journal of Antimicrobial Chemotherapy

Volumn 49, Issue 5, 2002, Pages 763-767

  Kutlin, Andrei ^a   Roblin, Patricia M ^a   Hammerschlag, Margaret R ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CYCLOHEXIMIDE; CYTOKINE; DOXYCYCLINE; ERYTHROMYCIN; GEMIFLOXACIN; INTERLEUKIN 6; INTERLEUKIN 8; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; INTERLEUKIN 12; NAPHTHYRIDINE DERIVATIVE; QUINOLONE DERIVATIVE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL SURVIVAL; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; HEP 2 CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INOCULATION; MODEL; MONOLAYER CULTURE; PERSISTENT INFECTION; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZITHROMYCIN; CELLS, CULTURED; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CYTOKINES; FLUOROQUINOLONES; HUMANS; INTERLEUKIN-12; INTERLEUKIN-6; INTERLEUKIN-8; NAPHTHYRIDINES;

EID: 0036001171     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf029     Document Type: Article

References (33)

1. Chlamydia pneumoniae and atherosclerosis
2. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: Comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate
3. Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia
4. Safety and efficacy of azithromycin in the treatment of community acquired pneumonia in children
5. Molecular evaluation of serial isolates from patients with persistent Chlamydia pneumoniae infections
6. Persistent infection with Chlamydia pneumoniae following acute respiratory illness
7. Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae
8. In vitro activity of gemifloxacin (SB-265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae
9. In vitro activity of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous infection model
10. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers
11. Pharmacokinetics and tissue penetration of gemofloxacin following a single oral dose
12. Effect of prolonged treatment with azithromycin, clarithromycin and levofloxacin on Chlamydia pneumoniae in a continuous infection model
13. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: Comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate
14. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro
15. Activity of gemifloxacin and other new quinolones against Chlamydia pneumoniae: A review
16. Ultrastructural study of Chlamydia pneumoniae in a continuous infection model
17. Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae
18. Growth in vascular cells and cytokine production by Chlamydia pneumoniae
19. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
20. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response
21. Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells
22. Production of IL-4 and IL-6 in HEp-2 cells infected with Chlamydia pneumoniae
23. The pathogenesis of atherosclerosis: A perspective for the 1990's
24. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall
25. Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cells
26. Effect of grepafloxacin on cytokine production in vitro
27. Effect of ciprofloxacin on the activation of the transcription factors nuclear factor κB, activator protein-1 and nuclear factor-interleukin-6, and interleukin-6 and interleukin-8 mRNA expression in a human endothelial cell line
28. Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis
29. Superinduction of cytokine gene transcription by ciprofloxacin
30. Effects of trovafloxacin on the IL-1-dependent activation of E-selectin in human endothelial cells in vitro
31. Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity
32. Roles of interleukin-12 and γ interferon in murine Chlamydia pneumoniae infection
33. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue